Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bromelain for stress and depressive anxiety in diabetic foot ulcer patients
IRCT20190708044148N2Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Apr 2022
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of bromelain in diabetic foot ulcer (DFU) and anxiety disorder, sponsored by Tehran University of Medical Sciences. Primary endpoints: Change in stress levels and Change in depressive anxiety. Started Apr 2022; status: completed.
02
Drugs
bromelain
03
Conditions
diabetic foot ulcer (DFU)anxiety disorder
Beyond the preview
Go deeper on IRCT20190708044148N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190708044148N2.